Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2588-2593
JournalDiabetologia
Volume59
Issue number12
DOIs
Publication statusPublished - Dec 2016

Cite this

@article{c5d7403bb4a3416f8e9d12537cfe808b,
title = "Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial",
keywords = "Dipeptidyl peptidase-4 inhibitor, Glucagon-like peptide-1 receptor agonist, Non-alcoholic fatty liver disease, Type 2 diabetes",
author = "Smits, {Mark M.} and Lennart Tonneijck and Muskiet, {Marcel H. A.} and Kramer, {Mark H. H.} and Pouwels, {Petra J. W.} and {Pieters-van den Bos}, {Indra C.} and Trynke Hoekstra and Michaela Diamant and {van Raalte}, {Daniel H.} and Cahen, {Djuna L.}",
year = "2016",
month = "12",
doi = "10.1007/s00125-016-4100-7",
language = "English",
volume = "59",
pages = "2588--2593",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

AU - Smits, Mark M.

AU - Tonneijck, Lennart

AU - Muskiet, Marcel H. A.

AU - Kramer, Mark H. H.

AU - Pouwels, Petra J. W.

AU - Pieters-van den Bos, Indra C.

AU - Hoekstra, Trynke

AU - Diamant, Michaela

AU - van Raalte, Daniel H.

AU - Cahen, Djuna L.

PY - 2016/12

Y1 - 2016/12

KW - Dipeptidyl peptidase-4 inhibitor

KW - Glucagon-like peptide-1 receptor agonist

KW - Non-alcoholic fatty liver disease

KW - Type 2 diabetes

U2 - 10.1007/s00125-016-4100-7

DO - 10.1007/s00125-016-4100-7

M3 - Article

VL - 59

SP - 2588

EP - 2593

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 12

ER -